Alphatec Spine, LDR, Globus Medical & more — 21 key notes

Spinal Tech

Here are 21 key notes on orthopedic and spine device companies over the past week.

Alphatec Holdings, parent company for Alphatec Spine, reported third quarter net revenue at $43 million.

 

Alphatec Spine shares rose by 12.87 percent for the last four weeks.

 

Alphatec Holdings announced that James R. Glynn is retired, effective Nov. 2.


 
BioMedical Enterprises launched its new Speed Hand and Wrist System.


 
BioRestorative Therapies received a patent for its licensed curved needle device.


 
Cerapedics received FDA approval to use the company's i-FACTOR Peptide Enhanced Bone Graft in anterior cervical discectomy and fusion procedures.

 

ConforMIS reported third quarter financial results after resolving a voluntary recall on Aug. 31, 2015.


 
EOS imaging announced a new installation of the EOS system in Japan.

 

Globus Medical reported an increase in worldwide net sales and net income for the third quarter of 2015.

 

Globus Medical also introduced the CREO MIS Pedicle Screw System.


 
Greatbatch completed its $1.73 billion acquisition of Lake Region Medical.

 

Implanet received regulatory approval from the Brazilian National Health Surveillance Agency to market its JAZZ Band platform.

 

Integra LifeSciences revenue was up 14.6 percent in the third quarter revenue over the same period last year.


 
K2M reported a 15.5 percent revenue increase in the third quarter of 2015.


 
LDR reported a third quarter revenue increase with strong Mobi-C and ROI-C sales growth.

 

Mainstay Medical applied for the CE Mark for ReActiv8.


 
Mazor Robotics reported a net revenue drop of 18 percent in the third quarter of 2015.


 
Medtech attained a $15 million investment by Ally Bridge Group, a global healthcare-focused investment group.


 
Rivanna Medical began selling its Accuro device.


 
Laser Spine Institute is participating in two upcoming clinical trials conducted by both Spinal Kinetics and Titan Spine.

 

Xtant Medical announced the first surgical implantation of OsteoSelect PLUS Demineralized Bone Matrix Putty, developed by its wholly owned subsidiary Bacterin.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers